jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Dec. 03, 2007

Dec. 17, 2018

jRCT2080220475

A randomized, double-blind, Phase II/III study of JR-013 in the patients with renal anemia receiving hemodialysis treatment

version:
date:

Kissei Pharmaceutical Co., Ltd.

rinsyousiken@pharm.kissei.co.jp

Interventional

A randomized, double-blind, parallel group study

2-3

20 Years and above, Renal anemia patients receiving hemodialysis treatment

20age old over
No limit

Both

Renal anemia

investigational material(s)
Generic name etc : JR-013
INN of investigational material :
Therapeutic category code : 399 Agents affecting metabolism, n.e.c.
Dosage and Administration for Investigational material : Injection

Efficacy and Safety

KISSEI PHARMACEUTICAL CO.,LTD.

JapicCTI-070485

History of Changes

No Publication date
9 Dec. 17, 2018 (this page) Changes
8 June. 16, 2010 Detail Changes
7 June. 16, 2010 Detail Changes
6 April. 02, 2010 Detail Changes
5 April. 02, 2010 Detail Changes
4 Dec. 03, 2007 Detail Changes
3 Dec. 03, 2007 Detail Changes
2 Dec. 03, 2007 Detail Changes
1 Dec. 03, 2007 Detail